OT antagonist 3

产品说明书

Print
Chemical Structure| 925703-75-9 同义名 : -
CAS号 : 925703-75-9
货号 : A925372
分子式 : C21H20N6O2
纯度 : 98%
分子量 : 388.423
MDL号 : N/A
存储条件:

Pure form

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 OT antagonist 3 is an oxytocin (OT) antagonist extracted from patent WO2007017752A1.
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01602510 Bipolar Disorder Phase 3 Completed - China, Guangdong ... 展开 >> GSK Investigational Site Guangzhou, Guangdong, China, 510180 GSK Investigational Site Guangzhou, Guangdong, China, 510370 GSK Investigational Site Guangzhou, Guangdong, China, 510630 China, Hebei GSK Investigational Site Baoding, Hebei, China, 071000 GSK Investigational Site Shijiazhuang, Hebei, China, 050000 China, Heilongjiang GSK Investigational Site Harbin, Heilongjiang, China, 150070 China, Henan GSK Investigational Site Changsha, Henan, China, 410011 GSK Investigational Site Xinxiang, Henan, China China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430022 China, Hunan GSK Investigational Site Changsha, Hunan, China China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 China, Shaanxi GSK Investigational Site Xi'an, Shaanxi, China, 710032 China, Shanxi GSK Investigational Site Taiyuan, Shanxi, China China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China, Yunnan GSK Investigational Site Kunming, Yunnan, China, 650032 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100083 GSK Investigational Site Beijing, China, 100088 GSK Investigational Site Beijing, China, 100096 GSK Investigational Site Shanghai, China, 200030 收起 <<
NCT02830906 Postoperative Nausea and Vomit... 展开 >>ing 收起 << Phase 3 Completed - -
NCT01602510 - Completed - -
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.87mL

2.57mL

1.29mL

25.75mL

5.15mL

2.57mL